01/09/2022 – Peptomer Therapeutics has secured BIG grant from Biotechnology Industry Research Assistance Council (BIRAC)
Project aims to develop novel oligomers as alternatives to antimicrobials, to fight global #antimicrobialresistance. Our innovative monomer technology enables controlled synthesis of novel antimicrobial oligomers on solid phase support. Our proof of concept data shows activity against various MDR strains of bacteria, a small step towards addressing AMR.
01/08/2022 Peptomer Therapeutics has secured NIDHI-PRAYAS grant
We are thankful to Department of Science & Technology (DST) and – Venture Center, Pune to support our ambition to crate a platform yielding new generation antimicrobial peptides (AMP) . Core of our innovation is a novel have invented novel amino acid platform technology, which could be used to generate a library of Antimicrobial Peptides (AMPs). Overall goal is to generate Proof of concept data to provide novel therapeutics to fight against AMR.
1/06/2022 Peptomer Therapeutics has secured a startup funding from NaaViC (Agri Business Incubation Centre), ICAR-NIVEDI.
To support our idea to generate novel drug delivery system to fight against drug resistant mastitis. Our innovative amino acid monomer technology enables to generate new class of drug delivery molecules
Peptomer Therapeutics secured incubator space at BSC BioNEST Bio-Incubator:
We are delighted to announce that Peptomer Therapeutics has secured incubation space at BSC BioNEST Bio-Incubator, Regional Centre for Biotechnology (RCB), Faridabad. In the beginning, three full-time Chemists will be working on breakthrough innovation addressing AMR.